about
Characterization of a novel coronavirus associated with severe acute respiratory syndromeOutbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus.Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population.Phylogeny of imported and reestablished wild polioviruses in theDemocratic Republic of the Congo from 2006 to 2011Molecular and Phenotypic Characterization of a Highly Evolved Type 2 Vaccine-Derived Poliovirus Isolated from Seawater in Brazil, 2014.High-Throughput Next-Generation Sequencing of Polioviruses.An outbreak of wild poliovirus in the Republic of Congo, 2010-2011Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern NigeriaEmergence of vaccine-derived polioviruses, Democratic Republic of Congo, 2004-2011.Genetic inactivation of poliovirus infectivity by increasing the frequencies of CpG and UpA dinucleotides within and across synonymous capsid region codons.Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).Vaccine-derived polioviruses.Environmental surveillance for polioviruses in the Global Polio Eradication Initiative.The role of supplementary environmental surveillance to complement acute flaccid paralysis surveillance for wild poliovirus in Pakistan - 2011-2013.Prolonged detection of indigenous wild polioviruses in sewage from communities in Egypt.Environmental surveillance of wild poliovirus circulation in Egypt--balancing between detection sensitivity and workload.Careers in Virology: Working at the Centers for Disease Control and Prevention.Progress toward polio eradication--Worldwide, 2013-2014.Update on Vaccine-Derived Polioviruses - Worldwide, January 2015-May 2016.Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia.Molecular epidemiology of wild poliovirus type 1 circulation in West and Central Africa, from 1997 to 1999, using genotyping with a restriction fragment length polymorphism assay.Surveillance Systems to Track Progress Toward Polio Eradication--Worldwide, 2014-2015.Vaccine-associated paralytic poliomyelitis and BCG-osis in an immigrant child with severe combined immunodeficiency syndrome - Texas, 2013.Update on Vaccine-Derived Polioviruses - Worldwide, January 2014-March 2015.Molecular Properties of Poliovirus Isolates: Nucleotide Sequence Analysis, Typing by PCR and Real-Time RT-PCR.Progress toward polio eradication - worldwide, 2014-2015.Tracking progress toward polio eradication - worldwide, 2013-2014.Field study of fecal excretion as a decision support tool in response to silent reintroduction of wild-type poliovirus 1 into Israel.Progress Toward Poliomyelitis Eradication--Nigeria, January 2014-July 2015.Circulating vaccine-derived polioviruses in the Extreme North region of Cameroon.Genetic analysis and characterization of wild poliovirus type 1 during sustained transmission in a population with >95% vaccine coverage, Israel 2013.Outbreak of type 1 wild poliovirus infection in adults, Namibia, 2006.Progress toward poliomyelitis eradication--Nigeria, January 2013-September 2014.Detection of vaccine-derived polioviruses in Mexico using environmental surveillance.Surveillance systems to track progress toward global polio eradication - worldwide, 2012-2013.Update on vaccine-derived polioviruses - worldwide, July 2012-December 2013.Wild poliovirus importation, Central African Republic.Outbreak of poliomyelitis in Finland in 1984-85 - Re-analysis of viral sequences using the current standard approach.Evolution of wild-type 1 poliovirus in two healthy siblings excreting the virus over a period of 6 months.
P50
Q28202401-D285F47D-39F6-4ABD-A9ED-256AB2E1F40BQ34118664-DFE0FFEE-E4C5-47D3-8C83-7DA20B447F2AQ34743352-864F6C05-B196-4D0F-B21F-0CEF78893546Q35000089-48D3FE4C-E1B9-425F-AD5C-8473A3FAF717Q35971462-023F1612-B9B1-43AE-A6AA-2AE128EEB548Q36215464-DA1AA01E-4697-423E-A1E1-BAA4FF1752EDQ36330167-AB09C2F4-F9B3-4032-8C40-4B2A17A7F5F7Q36433974-BDF6BEE2-60F2-41E7-8051-F92C265B6928Q36760045-A8515561-6C82-47E8-AF82-2592D65DC5B8Q37261927-3BBDBF79-13F3-45A3-9FAF-C96F6D2244DEQ37355985-BF3EAA8B-6B7F-4418-8FE4-C771CAA4D044Q38087428-4CBE0689-ED5D-4D70-9A3C-5EC13C4BCCD9Q38260375-38E23B12-1DF7-4A1E-A21E-0A5C3A82CFDCQ38260377-AD63E0B9-4083-42F2-AB10-77EA0F803242Q38662203-E0D4058C-6529-4267-9747-9D0E4F771FD8Q38984220-2C9BDB38-6362-4F2E-990C-2CA008C33406Q39079651-48256882-D1E2-4A73-949D-B6931F2BCE27Q39137449-4B969E82-C0BC-4ABC-ADD8-170605FFADE5Q39185258-8461D059-01EE-4D7C-9C5C-4AB975A8BF12Q39524580-7745CAB6-4162-4DC6-B06F-4F1757586278Q39954932-FE253E06-15A3-47C8-945E-A0B710B93A87Q40039356-8ED686CB-BAE0-4EF2-B19D-7C92C4FCEB00Q40110810-25478FEA-4512-4241-9FBE-B13677BC8DFAQ40195857-5DA6BE74-23AB-421A-AD57-B39060FA1DDCQ40824007-9F409BA7-9950-4FC4-A501-A306E748B91AQ40850180-AFD04C82-93E7-4BE6-BC61-C6EE816458B6Q40916676-D31FB7CF-98C7-4C1C-B97E-8A8E9A5F18C8Q41023590-5F387D01-0F18-40EB-80BA-D12EBB406BC6Q41340721-DDB9D90C-1644-484C-BD0B-FA3CB8BF47A1Q41466869-DE2D62A2-0114-4C13-B59C-CE18C01E8A4CQ41580247-714D3BAE-CFF3-4031-984D-E59CE42AD799Q41637704-D386602D-BC19-4FC6-A623-B8B0A771EC23Q41700718-AE9A6B51-2792-4FC8-BFB4-BD15A6055E1BQ41958467-1EB39E2F-971A-4EDE-BA4D-762924F98998Q42183593-61730288-3F4C-46CB-89C8-C4309808CA45Q42218111-9395BB6A-2E22-4A13-AF87-05ADC5FF77CCQ42223178-F21BCABD-7BA9-4DEF-920C-54B3B288B2A3Q43088427-13489CC9-100D-4D0B-BE7D-6DF26DD89308Q43645344-E3380E10-35BC-4ABF-81AE-96ACB506B4D6Q45693753-570E0753-316A-405B-8900-9F9933BB38D3
P50
name
Cara C Burns
@en
type
label
Cara C Burns
@en
prefLabel
Cara C Burns
@en